Galia Askarieh

528 citations
11 papers · 438 indexed · h-index 8
Topics
Hepatitis C virus research (8 papers)Liver Disease Diagnosis and Treatment (6 papers)Hepatitis B Virus Studies (5 papers)
Partner nations
SwedenSwitzerlandItaly

In The Last Decade

Galia Askarieh

11 papers receiving 424 citations

Peers

Galia Askarieh
Comparison fields: 5 of 57
  • Hepatology 311
  • Epidemiology 262
  • Immunology 96
  • Rheumatology 85
  • Molecular Biology 43
Replace I. Ketikoglou with:
I. Ketikoglou Greece
V Weich Germany
Barbara Langer Germany
Richard Hagan Ireland
E. Sanz‐de‐Villalobos Spain
M. Fort France
S. Klaymé Lebanon
Roger Naman Lebanon
Tania Dufeu‐Duchesne France
J. Flik Germany
Galia Askarieh relative to I. Ketikoglou Greece I. Ketikoglou's profile →
Citations per field
00.5×2.9×
I. Ketikoglou · 1×
Citations per year

Countries citing papers authored by Galia Askarieh

Since Specialization
Citations

This map shows the geographic impact of Galia Askarieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galia Askarieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galia Askarieh more than expected).

Fields of papers citing papers by Galia Askarieh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galia Askarieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galia Askarieh. The network helps show where Galia Askarieh may publish in the future.

Co-authorship network of co-authors of Galia Askarieh

This figure shows the co-authorship network connecting the top 25 collaborators of Galia Askarieh. A scholar is included among the top collaborators of Galia Askarieh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galia Askarieh. Galia Askarieh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 8
2 17
3 122
4 82
5 1
6
Ip-10 Is Associated With Il28b Variation And Predicts The First Phase Decline Of Hcv Rna And Outcome Of Therapy In Chronic Hepatitis C
2
7 27
8 101
9 36
10 1
11 41

About Galia Askarieh

Galia Askarieh is a scholar working on Hepatology, Epidemiology and Microbiology, having authored 11 papers that have together received 438 indexed citations. Recurring topics across this work include Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (5 papers). The work is most often cited by research in Hepatology (311 citations), Epidemiology (262 citations) and Rheumatology (85 citations). Galia Askarieh has collaborated with scholars based in Sweden, Switzerland and Italy. Frequent co-authors include Kristoffer Hellstrand, Martin Lagging, Francesco Negro, Johan Westin, Jonas Söderholm, Carlo Ferrari, Jean–Michel Pawlotsky, Stefan Zeuzem, Avidan U. Neumann and Ana I. Romero. Their work appears in journals such as Blood, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026